Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, including infectious disease testing, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
METHODS Special Issue: New Assays to Characterize Vaccination and Infection History
Single-plex targets developed will become components for future multiplex assays
Scientists in the Waterboer lab at the German Cancer Institute have developed the building blocks for a multiplex assay that will make it possible to quickly interrogate a person’s history of infection and vaccination. In a paper from Methods, the team reports developing individual assays for antibodies to several pathogens, noting that these assays could easily be combined into a multiplex assay in the future.
Continue Reading >
xMAP® Connect is structured to grow your network and to enable you to discover the endless applications of xMAP Technology. During the program, you will hear from multiplex experts about cutting-edge methods development and innovative projects from the research and clinical spaces, as well as connect with fellow researchers, Luminex partners, and Luminex specialists onsite.